Permissive factors for HIV-1 infection of macrophages

Journal of Leukocyte Biology

Volumn 68, Issue 3, 2000, Pages 303-310

  Wahl, S M ^a   Greenwell Wild, T ^a   Hale Donze, H ^a   Moutsopoulos, N ^a   Orenstein, J M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Mycobacterium avium; Nuclear factor ; Viral replication

Indexed keywords

CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

DISEASE PREDISPOSITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MACROPHAGE; MONOCYTE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; VIRUS REPLICATION;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM; MYCOBACTERIUM AVIUM;

EID: 0033635587     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease
2. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T cell-tropic virus population
3. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
4. Immunopathogenic mechanisms of HIV infection
5. Multiple modes to cellular activation and virus transmission in HIV infection. A role for chronically and latently infected cells in sustaining viral replication
6. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes
7. Macrophages, as a major source of HIV-during opportunistic infections
8. + T cells
9. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus
10. Mycobacterium avium complex (MAC) augments macrophage HIV-1 production and increases CCR5 expression
11. Immune stimulation and HIV-1 replication
12. Changes in circulating levels of HIV, CD4, and tissue expression of HIV in a patient with recent onset ulcerative colitis treated by surgery: A case report
13. The macrophage origin of HIV-infected multinucleated giant cells of hyperplastic tonsils and adenoids
14. Human immunodeficiency virus-rich multinucleated giant cells in the colon: A case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization
15. Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates
16. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
17. Changes in viral load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons
18. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia
19. Macrophage function in HIV infection
20. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil
21. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
22. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
23. Opportunistic infections in the era of HAART
24. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
25. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppresion
26. Re-emergence of HIV after stopping therapy
27. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
28. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
29. Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction
30. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
31. Predictors of survival in patients with AIDS and disseminated Mycobacterium avium complex disease
32. Mycobacterum avium interaction with macrophages and intestinal epithelial cells
33. Transforming growth factor beta. A potential macrophage and astrocyte-derived mediator of CNS dysfunction in AIDS
34. Circulating FcγRIII positive monocytes in AIDS patients. Induction by transforming growth factor beta
35. HIV-1 nef mediates lymphocyte chemotaxis and activation by infected macrophages
36. Human immunodeficiency virus type 1 infection alters chemokine b peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes
37. Differential cellular expression during HIV-1 infection of macrophages
38. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages
39. Mycobacterium avium complex (MAC) induction of macrophage-derived chemotatic factors(s)
40. Human immunodeficiency virus and its envelope glycoprotein down-regulate chemotatic ligand receptors and chemotactic function of peripheral blood monocytes
41. HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes
42. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1
43. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection
44. Virulent treponema pallidum, lipoprotein, and synthetic lipopetides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1
45. Lactobacilli and vaginal host defense: Activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kappaB
46. The NF-κB activation pathway: A paradigm in information transfer from membrane to nucleus
47. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, San Francisco city cohort, ALIVE study
48. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
49. Resistance to HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals bearing mutant alleles of the CCR5 chemokine receptor gene
50. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial backgrounds, and quantified risk
51. Gene organization and promoter function for CC chemokine receptor 5 CCR5
52. + T cells
53. Chemokines and HIV replication
54. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines
55. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of nuclear factor κB
56. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression
57. Interferon-gamma increases expression of chemokine receptor CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells
58. The relationship between tumor necrosis factor and human immunodeficiency virus gene expression in lymphoid tissue
59. CD4 T cells remain the major source of HIV-1 during end stage disease
60. The potential importance of HIV-induction of lymphocyte homing to lymph nodes
61. A novel mechanism of CD4 lymphocyte depletion involves HIV's effects on resting lymphocytes: Induction of lymph node homing and apoptosis upon secondary signaling through homing receptors
62. Direct and indirect mechanisms mediating apoptosis during HIV infection: Contribution to in vivo CD4 T cell depletion
63. An immunohistological approach to persistent lymphadenopathy and its revelance to AIDS
64. Diffential regulation of monocyte programmed cell death (apoptosis) by chemotactic factors and inflammatory cytokines
65. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis
66. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes
67. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
68. Immunobiology of mucosal HIV-1 infection
69. Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques
70. Clinical and epidemiologic features of primary HIV infection
71. Primary HIV infections associated with oral transmission
72. Secretory leukocyte protease inhibitor: A human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro
73. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription
74. The role of the oral environment in HIV-1 transmission
75. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV-1
76. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5
77. Selective elimination of HIV-1 infected cells using an IL-2 receptor specific cytotoxin
78. Expression of IL-2 receptors by monocytes from patients with acquired immune deficiency syndrome and induction of monocyte IL-2 receptors by human immunodeficiency virus-1 in vitro
79. Dipyridamole potentiates the inhibition by 3'-azido-3'-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte/macrophages
80. Synthesis and in vitro anti-HIV activity in human monocyte-derived macrophages of 2-oxothiazolidine-4(R) carboxylic acid derivatives